ArmInfo. On June 13, the Government of Armenia approved the adjusted investment program of one of the leading companies in the Armenian pharmaceutical market, Liqvor, providing it with an exemption from import customs duties on imported technological equipment, their components, raw and other materials.
According to the Minister of Economy of Armenia Tigran Khachatryan, the Cabinet of Ministers thus amends its own decree of February 6 of this yearN 72-A. The current privilege will be extended to equipment worth 92.4 million drams, the revenue loss of the state treasury will be about 1 million drams. As part of the investment program, with a budget of 7.6 billion drams, which should be used to further expand its own production, 1.7 billion drams have already been invested and 4 new jobs have been opened.
Earlier, ArmInfo reported that "Liqvor" intends to produce products worth 13 billion drams per year, of which 3.8 billion drams will be sold in the domestic market, 1 billion drams in the markets of the EAEU countries and 8 billion drams in the markets of the third countries.
"Liqvor" company was established in May 1991 and became the first private enterprise in Armenia, producing finished dosage forms. The company produces 60 items of infusion, injection, ophthalmic, hemostatic, preparations and exports its products to almost all CIS countries. In some areas, such as infusion therapy and ophthalmology, the company's drugs are recognized as basic in standard treatment regimens. The main export market of the company are the countries of Central Asia.